Analytical and Clinical Validation Requirements for Next Generation

Presented By: Ryan S. Robetorye, M.D., Ph.D.

Speaker Biography: Dr. Ryan S. Robetorye received his M.D. and Ph.D. degrees from Baylor College of Medicine in Houston, Texas. He is board certified in Clinical Pathology, Hematology, and Molecular Genetic Pathology and currently works as a Consultant at the Mayo Clinic in Phoenix, Arizona.

Webinar: Analytical and Clinical Validation Requirements for Next Generation Sequencing Laboratory-Developed Tests

Webinar Abstract: Next generation sequencing (NGS) has revolutionized molecular diagnostic testing. It is important to note that, as with many molecular diagnostic tests currently in clinical use, there are very few FDA-approved or FDA-cleared NGS assays, and thus analytical and clinical assay validation of laboratory-developed tests (LDTs) is essential to the application of NGS technology for clinical diagnostic testing.

Earn PACE Credits:

LabRoots on Social:
SnapChat: labroots_inc